US expert panel recommends Pfizer vaccination for children between 5 and 11 years old

Members of an American advisory committee voted in favor of vaccinating children between the ages of 5 and 11 with the “Pfizer” vaccine against Corona, paving the way for the vaccination of about 28 million children in the country.

The committee includes infectious disease experts, immunologists and pediatricians, and evaluated data collected by Pfizer and health authorities.

The opinion of these experts is an essential station in the licensing mechanism in the United States, as the US Food and Drug Administration rarely violates it.

 If the management vote is in line with the committee’s opinion, then the vaccine will be available to children of this age group.

If this happens within a few hours or days, the vaccine could become available for these children from early November.

At the end of the talks held by the committee and broadcast live on the Internet, its members voted in favor of children aged between 5 and 11 years receiving the vaccine, considering that its benefits outweigh its risks (17 voted in favor of vaccinating children while one member abstained).

Allowing children to be vaccinated is supposed to reassure a large number of parents who are worried about students returning to school.

To support the license application, Pfizer presented the results of a clinical trial that demonstrated a 90.7 percent efficacy of its vaccine for preventing symptomatic types of disease in children ages 5 to 11.

The titer was set at 10 micrograms per injection (to be given in two doses three weeks apart), compared to 30 micrograms for the older groups.

Source: “AFP” 

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button